Skip to content
Application 125031
- Type
- BLA
- Sponsor
- AMGEN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NEULASTA | PEGFILGRASTIM | SYRINGE | 6MG/0.6ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-190 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |
| 55513-192 | Neulasta | pegfilgrastim | Amgen Inc | BLA | Current |